Vivo Capital’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Vivo Capital’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,333,300	Closed	-$39.4M	–	56
2023 Q2	$39.4M	Hold	2,333,300	–	–	2.72%	9
2023 Q1	$19.9M	Hold	2,333,300	–	–	1.38%	15
2022 Q4	$20.2M	Buy	+2,333,300	New	+$18.8M	2.33%	15

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Vivo Capital's VECT Position: Q3 2023 in Review

Vivo Capital sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 2,333,300 shares — an estimated $39.4M sold.

Vivo Capital first reported a position in VECT in Q4 2022 and held it in 3 quarters. The position peaked at $39.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Vivo Capital reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Vivo Capital sold 2,333,300 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $39.4M.
Vivo Capital first reported a position in VectivBio Holding AG Ordinary Shares in Q4 2022 and held it in 3 quarters.
Vivo Capital's VectivBio Holding AG Ordinary Shares position peaked at $39.4M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Vivo Capital's 13F filing for Q3 2023, filed 8 Nov 2023.